PURE Bioscience Stock Price, News & Analysis (OTCMKTS:PURE) $0.12 0.00 (0.00%) (As of 11/30/2023 ET) Add Compare Share Share Today's Range$0.11▼$0.1250-Day Range$0.08▼$0.1252-Week Range$0.07▼$0.20Volume25,787 shsAverage Volume20,759 shsMarket Capitalization$13.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest About PURE Bioscience Stock (OTCMKTS:PURE)PURE Bioscience, Inc. develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds. It offers SDC-based disinfecting and sanitizing products, including PURE Hard Surface, a food contact surface sanitizer and disinfectant; PURE Control, a food contact processing aid for fresh produce and raw poultry; PURE Multi-Purpose and Floor Cleaner Concentrate to clean various resilient surfaces, including floors, glass, and food contact surfaces; and PURE Multi-Purpose Hi-Foam Cleaner Concentrate to clean stainless steel equipment, resilient floors, walls, and painted surfaces. The company also provides Axen30, a hard surface disinfectant; Axenohl, an antimicrobial formulation for use as a raw material ingredient in the manufacturing of consumer and commercial disinfecting and sanitizing products; and SILVÉRION, an antimicrobial formulation that is used against bacteria, viruses, yeasts, and molds. PURE Bioscience, Inc. was incorporated in 1992 and is headquartered in Rancho Cucamonga, California.Read More PURE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PURE Stock News HeadlinesNovember 30, 2023 | americanbankingnews.comPURE Bioscience (OTCMKTS:PURE) Share Price Crosses Above 200 Day Moving Average of $0.11November 21, 2023 | msn.comYoon says S. Korea, Britain will tackle security, digital challenges togetherDecember 1, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. October 30, 2023 | finance.yahoo.comPURE Bioscience Reports Fiscal 2023 Financial ResultsOctober 30, 2023 | finance.yahoo.comPURE Bioscience Reports Fiscal 2023 Financial ResultsOctober 25, 2023 | businesswire.comVedanta Biosciences to Host Investor Meetings at the Wells Fargo Virtual Private Biotech SymposiumOctober 11, 2023 | msn.comMichigan launches $20M talent campaignOctober 10, 2023 | businesswire.com“You Can in Michigan” Talent Marketing Campaign Launches to Build the Workforce of the Future and Welcome New Residents to the Great Lakes StateDecember 1, 2023 | Edge On The Street (Ad)Is Gold Really Boring?Many investors perceive gold as a "boring" investment. But according to MoneyWeek, that's a good thing. Gold helps investors sleep soundly as it preserves wealth and creates a hedge against inflation. Today, there's a unique way to invest in gold, with real advantages over coins and mining stocks. October 5, 2023 | businesswire.comVedanta Biosciences to Participate at Upcoming Investor ConferencesSeptember 20, 2023 | bizjournals.comLayoffs hit Morrisville firm as it scales back operationsSeptember 2, 2023 | msn.comCoffee, dolphins & other favorite things that might not exist in 30 yearsSeptember 2, 2023 | msn.comSaavy Naturals: What Happened To The Brand After Shark Tank?August 30, 2023 | finance.yahoo.comWILLOW ANNOUNCES FILING OF PATENT APPLICATION FOR PROCESS TO PRODUCE CORTICOSTEROIDS AT SIGNFICANTLY REDUCED COSTAugust 19, 2023 | msn.comThe Common Food Processing Step That's Detrimental To Our HealthAugust 8, 2023 | finance.yahoo.comWILLOW BIOSCIENCES REPORTS SECOND QUARTER 2023 FINANCIAL RESULTSAugust 3, 2023 | bizjournals.comMost Influential Business Women 2023: Gabriela Ramirez-Arellano helps entrepreneurs achieve their dreamsAugust 2, 2023 | finance.yahoo.comWILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON AUGUST 9July 29, 2023 | finance.yahoo.comPURE - PURE Bioscience, Inc.June 16, 2023 | finance.yahoo.comVinamilk forms strategic partnerships with top global companies and receives Purity Award for children's milk powderJune 16, 2023 | benzinga.comPURE Bioscience Stock (OTC:PURE), DividendsJune 14, 2023 | msn.comPURE Bioscience GAAP EPS of -$0.01, revenue of $0.41MJune 14, 2023 | finance.yahoo.comPURE Bioscience Reports Fiscal 2023 Third Quarter And Nine-Month Financial ResultsJune 14, 2023 | markets.businessinsider.comWhy Is NightHawk Biosciences (NHWK) Stock Up 26% Today?June 13, 2023 | yahoo.comWorld's most painful ant sting targets nerves in the same way scorpion venom doesJune 7, 2023 | finance.yahoo.comWILLOW BIOSCIENCES TO PRESENT AT THE EMERGING GROWTH CONFERENCE ON JUNE 14June 2, 2023 | msn.comTerran Biosciences Seals Deal With France's Pierre Fabre PharmaceuticalSee More Headlines Receive PURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PURE Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/30/2023Today12/01/2023Next Earnings (Estimated)12/12/2023Fiscal Year End7/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Miscellaneous chemical products Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:PURE CUSIPN/A CIK1006028 Webwww.purebio.com Phone(619) 596-8600Fax619-596-8790Employees11Year Founded1992Profitability EPS (Most Recent Fiscal Year)($0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,960,000.00 Net Margins-219.09% Pretax Margin-211.03% Return on Equity-364.82% Return on Assets-243.53% Debt Debt-to-Equity Ratio3.75 Current Ratio3.02 Quick Ratio2.85 Sales & Book Value Annual Sales$1.87 million Price / Sales7.06 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares111,860,000Free Float64,407,000Market Cap$13.20 million OptionableNot Optionable Beta0.10 Social Links Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Robert F. Bartlett (Age 78)President, CEO & Director Comp: $129.8kMr. Mark Stuart Elliott (Age 48)VP of Finance and Principal Financial & Accounting Officer Comp: $180kMr. Thomas Richard Myers (Age 71)Executive VP of Technology & Development and Director Comp: $200kKey CompetitorsArtemis TherapeuticsOTCMKTS:ATMST2 BiosystemsNASDAQ:TTOOArch TherapeuticsOTCMKTS:ARTHAIkido PharmaNASDAQ:AIKIAcelRx PharmaceuticalsNASDAQ:ACRXView All Competitors PURE Stock Analysis - Frequently Asked Questions How have PURE shares performed in 2023? PURE Bioscience's stock was trading at $0.0848 at the start of the year. Since then, PURE stock has increased by 39.2% and is now trading at $0.1180. View the best growth stocks for 2023 here. Are investors shorting PURE Bioscience? PURE Bioscience saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 900 shares, an increase of 125.0% from the October 31st total of 400 shares. Based on an average trading volume of 49,700 shares, the days-to-cover ratio is currently 0.0 days. View PURE Bioscience's Short Interest. When is PURE Bioscience's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, December 12th 2023. View our PURE earnings forecast. How were PURE Bioscience's earnings last quarter? PURE Bioscience, Inc. (OTCMKTS:PURE) issued its earnings results on Monday, October, 30th. The company reported ($0.03) earnings per share for the quarter. The firm earned $1.47 million during the quarter. PURE Bioscience had a negative trailing twelve-month return on equity of 364.82% and a negative net margin of 219.09%. What other stocks do shareholders of PURE Bioscience own? Based on aggregate information from My MarketBeat watchlists, some companies that other PURE Bioscience investors own include NVIDIA (NVDA), Boeing (BA), Overstock.com (OSTK), Pure Storage (PSTG), Riot Platforms (RIOT), Enphase Energy (ENPH), Mastercard (MA), Main Street Capital (MAIN), Twilio (TWLO) and How do I buy shares of PURE Bioscience? Shares of PURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (OTCMKTS:PURE) was last updated on 12/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PURE Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.